Search results for "kinetics"

showing 10 items of 2224 documents

Enhanced thermodynamic and kinetic stability of calix[4]arene dimers locked in the cone conformation.

2004

Wide rim tetraurea derivatives (2a,b) have been prepared from a calix[4]arene rigidified in the cone conformation by two diethyleneglycol ether bridges between adjacent oxygens. In comparison to the analogous tetraurea derivatives (3a,b) of a tetrapentoxy calix[4]arene, 2a,b show an increased thermodynamic stability in mixtures of CDCl(3) and DMSO-d(6). Their kinetic stability as expressed by the rate of guest exchange (benzene or cyclohexane against the solvent benzene-d(6)) is also strongly increased by factors of 30-38. Noticeable differences for the inclusion of selected guests are found.

Magnetic Resonance SpectroscopyCyclohexaneMolecular StructureStereochemistryDimerOrganic ChemistryMolecular ConformationEtherInclusion compoundSolventchemistry.chemical_compoundCrystallographyKineticschemistryPhenolsCalixareneThermodynamicsUreaChemical stabilityCalixarenesBenzeneThe Journal of organic chemistry
researchProduct

Cooperative onset of a different state of water in the presence of macromolecules.

1973

Magnetic Resonance SpectroscopyTime FactorsMacromolecular SubstancesGeneral NeuroscienceMacromolecular SubstancesKineticsElectron Spin Resonance SpectroscopyTemperatureWaterNuclear magnetic resonance spectroscopyGeneral Biochemistry Genetics and Molecular BiologyAgarKineticsHistory and Philosophy of ScienceSolubilityComputational chemistrySolubilityGelsMathematicsMacromoleculeAnnals of the New York Academy of Sciences
researchProduct

Temperature affects the ontogeny of sexually dimorphic cuticular hydrocarbons inDrosophila melanogaster

2002

0022-0949 (Print) Journal Article Research Support, Non-U.S. Gov't; Hydrocarbons on the cuticle of mature Drosophila melanogaster flies play a crucial role in mate recognition, and protect against dehydration. We measured the effect of temperature on mature cuticular hydrocarbons (CHs) by (i) rearing two control strains at different temperatures, (ii) shifting the temperature after metamorphosis and (iii) inducing a single heat-shock pulse in control and heat-sensitive transgenic strains, over a period of 3 days following adult eclosion. This study describes the time course of the events involved in the production of male- and female-predominant CHs. We also found that 'immature' CHs, sexua…

Male0106 biological sciencesHot TemperaturePhysiologyOntogenymedia_common.quotation_subjectPeriod (gene)CuticleTransgeneZoologyGenetically ModifiedHydrocarbons/analysis/*metabolismAquatic Science010603 evolutionary biology01 natural sciencesAnimals Genetically Modified03 medical and health sciencesBotanyAnimalsMetamorphosisMolecular BiologyEcology Evolution Behavior and Systematics030304 developmental biologymedia_commonSex Characteristics0303 health sciencesintegumentary systembiologyfungibiology.organism_classificationHeatHydrocarbonsSexual dimorphismKineticsDrosophila melanogasterInsect ScienceTime courseDrosophila melanogaster/*growth & development/metabolismFemaleAnimal Science and ZoologyDrosophila melanogasterJournal of Experimental Biology
researchProduct

Epstein-Barr virus DNA load kinetics analysis in allogeneic hematopoietic stem cell transplant recipients: Is it of any clinical usefulness?

2017

Abstract Background There is a lack of clinical information regarding the usefulness of plasma Epstein-Barr virus (EBV) DNA load kinetics analyses in the management of EBV infections in allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. Namely, it remains unknown whether this type of analysis can help physicians to anticipate the development of high-level EBV DNAemia episodes requiring rituximab treatment or predict the risk of recurrent EBV DNAemia or post-transplant lymphoproliferative disorders (PTLDs). Study design Unicentric, retrospective, observational study including 142 consecutive patients undergoing T-cell replete allo-HSCT. The plasma EBV DNA load was mon…

Male0301 basic medicineEpstein-Barr Virus InfectionsHerpesvirus 4 HumanDna loadmedicine.medical_treatmentLymphoproliferative disordersHematopoietic stem cell transplantationPolymerase Chain ReactionVirus03 medical and health sciencesAntineoplastic Agents Immunological0302 clinical medicinehemic and lymphatic diseasesVirologyClinical informationHumansTransplantation HomologousMedicineRetrospective Studiesbusiness.industryHematopoietic Stem Cell TransplantationEpstein-Barr virus DNAvirus diseasesViral Loadmedicine.diseaseTransplant RecipientsKinetics030104 developmental biologyInfectious DiseasesDNA ViralImmunologyFemaleRituximabReagent Kits DiagnosticAllogeneic hematopoietic stem cell transplantRituximabbusiness030215 immunologymedicine.drugJournal of Clinical Virology
researchProduct

Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma : Final …

2016

Purpose Blinatumomab is a CD19/CD3 BiTE (bispecific T-cell engager) antibody construct for the treatment of Philadelphia chromosome–negative acute B-lymphoblastic leukemia. We evaluated blinatumomab in relapsed/refractory B-cell non-Hodgkin lymphoma (NHL). Patients and Methods This 3 + 3 design, phase I dose-escalation study determined adverse events and the maximum tolerated dose (MTD) of continuous intravenous infusion blinatumomab in patients with relapsed/refractory NHL. Blinatumomab was administered over 4 or 8 weeks at seven different dose levels (0.5 to 90 μg/m2/day). End points were incidence of adverse events, pharmacokinetics, pharmacodynamics, and overall response rate. Results B…

Male0301 basic medicineOncologyCancer ResearchCD3 ComplexT-Lymphocytesmedicine.medical_treatmentMedizinLymphoma Mantle-CellLymphocyte Activation0302 clinical medicineRecurrenceGermanyhemic and lymphatic diseasesAntibodies BispecificMedicineMolecular Targeted TherapyInfusions IntravenousLymphoma FollicularLymphoma Non-HodgkinRemission InductionMiddle AgedLeukemiaTreatment OutcomeOncology030220 oncology & carcinogenesisFemaleBlinatumomabImmunotherapymedicine.drugAdultmedicine.medical_specialtyLymphoma B-CellMaximum Tolerated DoseAntigens CD19Antineoplastic AgentsDrug Administration Schedule03 medical and health sciencesPharmacokineticsRefractoryInternal medicineHumansAdverse effectbusiness.industryImmunotherapymedicine.diseaseLymphomaSurgery030104 developmental biologyPharmacodynamicsNervous System Diseasesbusiness
researchProduct

Myristic acid is associated to low plasma HDL cholesterol levels in a Mediterranean population and increases HDL catabolism by enhancing HDL particle…

2016

Background: HDL-C plasma levels are modulated by dietary fatty acid (FA), but studies investigating dietary supplementation in FA gave contrasting results. Saturated FA increased HDL-C levels only in some studies. Mono-unsaturated FA exerted a slight effect while poly-unsaturated FA mostly increased plasma HDL-C. Aims: This study presents two aims: i) to investigate the relationship between HDL-C levels and plasma FA composition in a Sicilian population following a "Mediterranean diet", ii) to investigate if FA that resulted correlated with plasma HDL-C levels in the population study and/or very abundant in the plasma were able to affect HDL catabolism in an "in vitro" model of cultured hep…

Male0301 basic medicineSettore MED/09 - Medicina InternaMediterranean dietCellHepG2 cellMyristic acid030204 cardiovascular system & hematologyDiet MediterraneanMyristic AcidSettore MED/13 - Endocrinologiachemistry.chemical_compound0302 clinical medicineSicilyeducation.field_of_studyLiver NeoplasmsHep G2 CellsMiddle Agedmedicine.anatomical_structurePopulation studyFemalelipids (amino acids peptides and proteins)Composition (visual arts)Cholesterol EstersCardiology and Cardiovascular MedicinePopulation studyProtein BindingAdultmedicine.medical_specialtyCarcinoma HepatocellularPopulationHDL cholesterol level03 medical and health sciencesInternal medicinemedicineHumanseducationAgedFatty acids; HDL cholesterol levels; HepG2 cells; Population study; Cardiology and Cardiovascular MedicineCatabolismbusiness.industryCholesterolCholesterol HDLMembrane Proteinsnutritional and metabolic diseasesFatty acidKinetics030104 developmental biologyEndocrinologychemistrybusinessBiomarkersHeparan Sulfate ProteoglycansAtherosclerosis
researchProduct

A preclinical study to model taurine pharmokinetics in the undernourished rat

2018

AbstractMalnutrition is a common feature of chronic and acute diseases, often associated with a poor prognosis, including worsening of clinical outcome, owing, among other factors, to dysfunction of the most internal organs and systems affecting the absorption, metabolism and elimination of drugs and nutrients. Taurine is involved in numerous biological processes and is required in increased amounts in response to pathological conditions. The aim of this study was to describe the behaviour of taurine in well-nourished (WN) rats and to analyse the influence of protein–energy undernutrition on the pharmacokinetic (PK) parameters of taurine, using a PK model. Wistar rats were randomly distribu…

Male0301 basic medicineTaurineTaurinePopulationSerum albuminAdministration OralBiological AvailabilityNutritional StatusMedicine (miscellaneous)PharmacologyExcretionRandom Allocation03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePharmacokineticsAnimalsMedicineDistribution (pharmacology)030212 general & internal medicineRats Wistareducationeducation.field_of_studyNutrition and DieteticsDose-Response Relationship DrugbiologyReabsorptionbusiness.industryRatsNONMEM030104 developmental biologychemistryInjections Intravenousbiology.proteinFood DeprivationbusinessBritish Journal of Nutrition
researchProduct

Cerebrospinal fluid pharmacokinetics of ceftaroline in neurosurgical patients with an external ventricular drain

2019

IF 5.217; International audience; BackgroundOwing to its antibacterial properties, ceftaroline could be attractive for prevention or treatment of bacterial post-neurosurgical meningitis/ventriculitis. However, few data are available concerning its meningeal concentrations.ObjectivesTo investigate ceftaroline CSF pharmacokinetics in ICU patients with an external ventricular drain (EVD).MethodsPatients received a single 600 mg dose of ceftaroline as a 1 h intravenous infusion. Blood and CSF samples were collected before and 0.5, 1, 3, 6, 12 and 24 h after the end of the infusion. Concentrations were assayed in plasma and CSF by LC–MS/MS. A two-step compartmental pharmacokinetic analysis was c…

Male0301 basic medicinemedicine.medical_treatmentprotein bindinginfusion proceduresintensive care unitCerebral VentriclesCerebral VentriculitisPostoperative Complications0302 clinical medicineCerebrospinal fluidTandem Mass SpectrometryPharmacology (medical)030212 general & internal medicineInfusions Intravenousintravenous infusion proceduresmeningitisMiddle AgedAnti-Bacterial Agents3. Good healthIntensive Care UnitsInfectious DiseasesAnesthesiaDrainageceftarolineFemalepharmacokineticsMeningitisAdultMicrobiology (medical)VentriculostomyAdolescent030106 microbiologyCmax[SDV.MHEP.CHI]Life Sciences [q-bio]/Human health and pathology/Surgerycerebrospinal fluidMeningitis BacterialYoung Adult03 medical and health sciencesPharmacokineticsavian ventriculitismedicineVentriculitisHumansDistribution (pharmacology)plasmaAgedbacterial post-neurosurgical meningitis/ventriculitisPharmacologybusiness.industryModels Theoreticalmedicine.diseaseneurosurgical proceduresCephalosporinsventriculostomybusinessChromatography LiquidExternal ventricular drainJournal of Antimicrobial Chemotherapy
researchProduct

Evidence of a specialized transport mechanism for the intestinal absorption of baclofen

1989

Absorption of the spasmolytic drug baclofen in three selected intestinal segments of living anaesthetized rats in situ, is shown to be a specialized transport mechanism obeying Michaelis-Menten kinetics. Equation parameters were calculated through different procedures, whose features are discussed. A computer method based on the integrated form of Michaelis-Menten equation which reproduces the entire time course of drug absorption from the data found in three intestinal perfusion series at different initial concentrations, yielded Vm and Km values of 12.0 mg h-1 and 8.0 mg, respectively, in the mean segment of the small intestine, a rather selective absorption site for baclofen. Lesser but …

MaleAbsorption (pharmacology)AzidesBaclofenKineticsBiological Transport ActivePharmaceutical ScienceModels BiologicalIntestinal absorptionDiffusionchemistry.chemical_compoundPharmacokineticsmedicineAnimalsPharmacology (medical)PharmacologyRats Inbred StrainsGeneral MedicineSmall intestineRatsBioavailabilityBaclofenmedicine.anatomical_structureIntestinal AbsorptionchemistryBiochemistryBiophysicsSodium azideAntipyrineBiopharmaceutics & Drug Disposition
researchProduct

Interaction of Taurine on Baclofen Intestinal Absorption: A Nonlinear Mathematical Treatment using Differential Equations to Describe Kinetic Inhibit…

1996

Previous studies showed that the in situ absorption of baclofen in rat jejunum was inhibited by beta-alanine, a nonessential amino acid, and therefore mediated, at least in part, by some beta-amino acid carrier. In this paper a similar study was undertaken using taurine, a sulfonic beta-amino acid, in order to evaluate its effect and to establish a general inhibition model. To achieve this goal, remaining concentrations of inhibitor were also measured and incorporated into the model. Previously, kinetic absorption in situ parameters for taurine in free solution were obtained: Vm = 27.73 +/- 9.99 mM h-1, K(m) = 8.06 +/- 2.82 mM, Ka (passive difussion component) = 0.40 +/- 0.28 h-1. Isotonic …

MaleAbsorption (pharmacology)BaclofenTaurineTaurinePharmaceutical ScienceIntestinal absorptionchemistry.chemical_compoundNon-competitive inhibitionLeucineAnimalsRats Wistargamma-Aminobutyric Acidchemistry.chemical_classificationChromatographyMuscle Relaxants CentralRatsAmino acidKineticsBaclofenIntestinal AbsorptionModels ChemicalchemistryBiochemistrybeta-AlanineLeucinePerfusionJournal of Pharmaceutical Sciences
researchProduct